pubmed-article:15054673 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15054673 | lifeskim:mentions | umls-concept:C0677616 | lld:lifeskim |
pubmed-article:15054673 | lifeskim:mentions | umls-concept:C0061851 | lld:lifeskim |
pubmed-article:15054673 | lifeskim:mentions | umls-concept:C0520909 | lld:lifeskim |
pubmed-article:15054673 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
pubmed-article:15054673 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:15054673 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:15054673 | pubmed:dateCreated | 2004-9-29 | lld:pubmed |
pubmed-article:15054673 | pubmed:abstractText | Ondansetron has been used widely in plastic surgery to prevent postoperative nausea and vomiting. A literature search showed controversial dosages of this drug, and because of its short half-life, its use only before anesthetic induction could have a limited effect. The purpose of this study was to assess the efficacy of intravenous (IV) ondansetron (4 mg) for aesthetic plastic surgery performed with the patient under general anesthesia and the prophylaxis of postoperative nausea and vomiting (PONV) in two situations: (a) only before anesthetic induction and (b) before anesthetic induction and immediately before extubation. | lld:pubmed |
pubmed-article:15054673 | pubmed:language | eng | lld:pubmed |
pubmed-article:15054673 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15054673 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15054673 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15054673 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15054673 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15054673 | pubmed:issn | 0364-216X | lld:pubmed |
pubmed-article:15054673 | pubmed:author | pubmed-author:NahasFabio... | lld:pubmed |
pubmed-article:15054673 | pubmed:author | pubmed-author:FarahAndréia... | lld:pubmed |
pubmed-article:15054673 | pubmed:author | pubmed-author:FerreiraLydia... | lld:pubmed |
pubmed-article:15054673 | pubmed:author | pubmed-author:BarbosaMarcus... | lld:pubmed |
pubmed-article:15054673 | pubmed:author | pubmed-author:BarianiRobert... | lld:pubmed |
pubmed-article:15054673 | pubmed:author | pubmed-author:JoãoBenedito... | lld:pubmed |
pubmed-article:15054673 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15054673 | pubmed:volume | 28 | lld:pubmed |
pubmed-article:15054673 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15054673 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15054673 | pubmed:pagination | 33-6 | lld:pubmed |
pubmed-article:15054673 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:meshHeading | pubmed-meshheading:15054673... | lld:pubmed |
pubmed-article:15054673 | pubmed:articleTitle | Ondansetron for the prevention of postoperative nausea and vomiting: which is the best dosage for aesthetic plastic surgery? | lld:pubmed |
pubmed-article:15054673 | pubmed:affiliation | São Paulo, SP / Brazil. drmbarbosa@ig.com.br | lld:pubmed |
pubmed-article:15054673 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15054673 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15054673 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |